Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-01 4:16 pm Purchase | 2024-06-27 | 13D | Connect Biopharma Holdings Limited CNTB | Panacea Venture Healthcare Fund II, L.P. | 13,410,000 24.300% | 1,410,000 (+11.75%) | Filing History |
| 2024-02-27 9:00 pm Purchase | 2024-02-23 | 13D | Connect Biopharma Holdings Limited CNTB | Panacea Venture Healthcare Fund II, L.P. | 12,000,000 21.800% | 3,100,000 (+34.83%) | Filing History |
| 2024-02-27 4:19 pm Sale | 2024-02-23 | 13D | Connect Biopharma Holdings Limited CNTB | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,062,871 (Position Closed) | Filing History |
| 2024-02-13 4:30 pm Purchase | 2024-02-12 | 13D | Connect Biopharma Holdings Limited CNTB | Panacea Venture Healthcare Fund II, L.P. | 8,900,000 16.200% | 8,900,000 (New Position) | Filing History |
| 2024-02-13 4:27 pm Purchase | 2023-12-31 | 13G | Connect Biopharma Holdings Limited CNTB | BioFortune Inc | 6,728,292 12.100% | 511,767 (+8.23%) | Filing History |
| 2024-02-13 4:18 pm Purchase | 2023-12-31 | 13G | Connect Biopharma Holdings Limited CNTB | Wei Zheng | 6,487,545 11.700% | 262,198 (+4.21%) | Filing History |
| 2023-12-20 4:30 pm Sale | 2023-12-18 | 13D | Connect Biopharma Holdings Limited CNTB | RA CAPITAL MANAGEMENT L.P. | 3,062,871 5.600% | -2,061,438 (-40.23%) | Filing History |
| 2023-12-14 4:30 pm Sale | 2023-12-12 | 13D | Connect Biopharma Holdings Limited CNTB | RA CAPITAL MANAGEMENT L.P. | 5,124,309 9.300% | -830,702 (-13.95%) | Filing History |
| 2023-12-04 5:20 pm Sale | 2023-11-30 | 13D | Connect Biopharma Holdings Limited CNTB | RA CAPITAL MANAGEMENT L.P. | 5,955,011 10.800% | -1,035,992 (-14.82%) | Filing History |
| 2023-10-04 5:26 pm Purchase | 2023-10-02 | 13G | Connect Biopharma Holdings Limited CNTB | Huang James | 5,995,000 10.900% | 3,175,000 (+112.59%) | Filing History |
| 2023-02-14 06:27 am Purchase | 2022-12-31 | 13G | Connect Biopharma Holdings Limited CNTB | Qiming Corporate GP V, Ltd. | 3,198,755 5.800% | 3,198,755 (New Position) | Filing History |
| 2023-02-13 5:20 pm Purchase | 2022-12-31 | 13G | Connect Biopharma Holdings Limited CNTB | Shanghai Minhui Enterprise Management Consulting Partnership (Limited Partnership) | 5,306,149 9.600% | 5,306,149 (New Position) | Filing History |
| 2023-02-13 5:13 pm Purchase | 2022-12-31 | 13G | Connect Biopharma Holdings Limited CNTB | Wei Zheng | 6,225,347 11.300% | 174,103 (+2.88%) | Filing History |
| 2023-02-13 5:13 pm Purchase | 2022-12-31 | 13G | Connect Biopharma Holdings Limited CNTB | BioFortune Inc | 6,216,525 11.300% | 100,134 (+1.64%) | Filing History |
| 2023-02-09 09:59 am Sale | 2023-02-09 | 13G | Connect Biopharma Holdings Limited CNTB | FMR LLC | 82 0.000% | -3,417,482 (-100.00%) | Filing History |
| 2023-01-03 4:31 pm Purchase | 2022-12-22 | 13G | Connect Biopharma Holdings Limited CNTB | Huang James | 2,820,000 5.100% | 2,820,000 (New Position) | Filing History |
| 2022-02-25 4:43 pm Purchase | 2021-12-31 | 13G | Connect Biopharma Holdings Limited CNTB | Wei Zheng | 6,051,244 11.000% | 6,051,244 (New Position) | Filing History |
| 2022-02-25 4:42 pm Purchase | 2021-12-31 | 13G | Connect Biopharma Holdings Limited CNTB | BioFortune Inc | 6,116,391 11.100% | 6,116,391 (New Position) | Filing History |
| 2022-02-15 06:05 am Purchase | 2021-12-31 | 13G | Connect Biopharma Holdings Limited CNTB | Advantech Capital II L.P. | 4,762,185 8.500% | 4,762,185 (New Position) | Filing History |
| 2022-02-14 06:13 am Purchase | 2021-12-31 | 13G | Connect Biopharma Holdings Limited CNTB | Qiming Venture Partners VII L.P. | 3,198,755 5.800% | 3,198,755 (New Position) | Filing History |